What is the interaction between dihydrocodeine and 5-Hydroxytryptophan (5-HTP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Interaction between Dihydrocodeine and 5-Hydroxytryptophan (5-HTP)

There is no direct evidence in the provided studies to suggest an interaction between dihydrocodeine and 5-Hydroxytryptophan (5-HTP).

Available Information on 5-HTP

  • 5-HTP is a precursor to serotonin and is used to treat depression and other serotonin-related diseases 1, 2, 3.
  • The efficacy of 5-HTP in treating depression is still uncertain due to limited high-quality studies 1.
  • 5-HTP can be contraindicated for depression in some patients, and its use should be approached with caution 2.
  • The physiological effects of 5-HTP have been studied in both animal and human clinical trials, and it has been found to play a role in various neurological and metabolic diseases 3.

Pharmacology of 5-HTP

  • 5-HTP can be administered with carbidopa to increase its bioavailability and reduce peripheral side effects 4, 5.
  • The pharmacokinetics of 5-HTP have been studied, and it has been found to exhibit dose-dependent increases in cortisol and prolactin concentrations 4, 5.
  • The use of 5-HTP as a challenge test for the serotonergic system has been investigated, and it has been found to be effective but limited by side effects such as nausea and vomiting 4, 5.

Limitations

  • There are no studies available that directly investigate the interaction between dihydrocodeine and 5-HTP.
  • Further research is needed to fully understand the effects and interactions of 5-HTP 1, 2, 3.

References

Research

Tryptophan and 5-hydroxytryptophan for depression.

The Cochrane database of systematic reviews, 2001

Research

5-HTP efficacy and contraindications.

Neuropsychiatric disease and treatment, 2012

Research

Pharmacology of rising oral doses of 5-hydroxytryptophan with carbidopa.

Journal of psychopharmacology (Oxford, England), 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.